No abstract available
MeSH terms
-
Aged
-
Alzheimer Disease / diagnosis
-
Alzheimer Disease / drug therapy*
-
Cholinesterase Inhibitors / administration & dosage*
-
Cholinesterase Inhibitors / adverse effects
-
Cognitive Dysfunction / diagnosis
-
Cognitive Dysfunction / drug therapy*
-
Delirium / diagnosis
-
Delirium / drug therapy
-
Diagnosis, Differential
-
Disease Progression
-
Early Termination of Clinical Trials
-
Hospitalization*
-
Humans
-
Intensive Care Units
-
Phenylcarbamates / administration & dosage
-
Phenylcarbamates / adverse effects
-
Randomized Controlled Trials as Topic
-
Rivastigmine
Substances
-
Cholinesterase Inhibitors
-
Phenylcarbamates
-
Rivastigmine